Bifidobacterium infantis suppression of Peyer’s patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+CD25+ T cell numbers

Belkaid, 2005, Natural regulatory T cells in infectious disease, Nat. Immunol., 6, 353, 10.1038/ni1181 Sun, 2007, Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid, J. Exp. Med., 204, 1775, 10.1084/jem.20070602 Karim, 2004, Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25−CD4+ precursors in a thymus-independent process, J. Immunol., 172, 923, 10.4049/jimmunol.172.2.923 Coombes, 2007, A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism, J. Exp. Med., 204, 1757, 10.1084/jem.20070590 Chen, 2003, Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J. Exp. Med., 198, 1875, 10.1084/jem.20030152 Di Giacinto, 2005, Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells, J. Immunol., 174, 3237, 10.4049/jimmunol.174.6.3237 Fuller, 1989, Probiotics in man and animals, J. Appl. Bacteriol., 66, 365, 10.1111/j.1365-2672.1989.tb05105.x O’Mahony, 2005, Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles, Gastroenterology, 128, 541, 10.1053/j.gastro.2004.11.050 Marteau, 2001, Protection from gastrointestinal diseases with the use of probiotics, Am. J. Clin. Nutr., 73, 430S, 10.1093/ajcn/73.2.430s Jonkers, 2003, Probiotics and inflammatory bowel disease, J. R. Soc. Med., 96, 167, 10.1258/jrsm.96.4.167 Gorbach, 1990, Lactic acid bacteria and human health, Ann. Med., 22, 37, 10.3109/07853899009147239 Campieri, 1999, Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?, Gastroenterology, 116, 1246, 10.1016/S0016-5085(99)70029-6 Tannock, 1997, Probiotic properties of lactic-acid bacteria: plenty of scope for fundamental R & D, Trends Biotechnol., 15, 270, 10.1016/S0167-7799(97)01056-1 Silva, 2004, Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice, J. Appl. Microbiol., 97, 29, 10.1111/j.1365-2672.2004.02265.x O’Mahony, 2001, Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice, Aliment. Pharmacol. Ther., 15, 1219, 10.1046/j.1365-2036.2001.01027.x McCarthy, 2003, Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance, Gut, 52, 975, 10.1136/gut.52.7.975 Isolauri, 2002, Probiotics: a role in the treatment of intestinal infection and inflammation?, Gut, 50, III54, 10.1136/gut.50.suppl_3.iii54 R. Frei, R.P. Lauener, R. Crameri, L. O’Mahony, Microbiota and dietary interactions: an update to the hygiene hypothesis? Allergy 67, 2012, 451–61. Symonds, 2012, Bifidobacterium infantis 35624 protects against Salmonella-induced reductions in digestive enzyme activity in mice by attenuation of the host inflammatory response, Clin. Trans. Gastroenterol., 3, e15, 10.1038/ctg.2012.9 O’Mahony, 2008, Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation, PLoS Pathog., 4, e1000112, 10.1371/journal.ppat.1000112 Konieczna, 2012, Portrait of an immunoregulatory Bifidobacterium, Gut Microbes, 3, 261, 10.4161/gmic.20358 O’Hara, 2006, Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius, Immunology, 118, 202, 10.1111/j.1365-2567.2006.02358.x Sibartie, 2009, Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria, BMC Immunol., 10, 54, 10.1186/1471-2172-10-54 Whorwell, 2006, Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome, Am. J. Gastroenterol., 101, 1581, 10.1111/j.1572-0241.2006.00734.x Riesenberg-Wilmes, 1996, Role of the acid tolerance response in virulence of Salmonella typhimurium, Infect. Immun., 64, 1085, 10.1128/IAI.64.4.1085-1092.1996 Maurer, 2004, Macrophage inflammatory protein-1, Int. J. Biochem. Cell. Biol., 36, 1882, 10.1016/j.biocel.2003.10.019 Luster, 2002, The role of chemokines in linking innate and adaptive immunity, Curr. Opin. Immunol., 14, 129, 10.1016/S0952-7915(01)00308-9 Appay, 2001, RANTES: a versatile and controversial chemokine, Trends Immunol., 22, 83, 10.1016/S1471-4906(00)01812-3 Schall, 1991, Biology of the RANTES/SIS cytokine family, Cytokine, 3, 165, 10.1016/1043-4666(91)90013-4 P. Konieczna, D. Groeger, M. Ziegler, R. Frei, R. Ferstl, F. Shanahan, E.M. Quigley, B. Kiely, C.A. Akdis, L. O’Mahony, Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 61, 2012, 354–66. Dal Secco, 2009, Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes, PLoS One, 4, e7696, 10.1371/journal.pone.0007696 Morlacchi, 2011, Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation, J. Immunol., 186, 6807, 10.4049/jimmunol.1003265 Kim, 2012, Neutrophil chemotaxis within a competing gradient of chemoattractants, Anal. Chem., 84, 6070, 10.1021/ac3009548